Biotech
Pharma
Bioprocessing
Health
Sustainability
More
Hello.
Popular Content.
Lundbeck Reports Seizure Reductions in Rare Childhood-Onset Epilepsies
AES 2025 data highlight continued seizure improvement in patients treated with bexicaserin through long-term follow-up.
Belite Bio Announces Landmark Phase 3 Success for Stargardt Disease
Lonza Strengthens Rapid Microbiology Portfolio With Planned Acquisition of Redberry
Digital Cognitive Therapy Delivers Striking Cognitive Gains for UK Care Home Residents
Hidden Contrails in Clouds Could Be Worsening Aviation’s Climate Impact
Study Shows TREMFYA® Slows Psoriatic Arthritis Progression at 48 Weeks
WHO Prequalifies Shanchol®, Securing Global Supply of India’s Oral Cholera Vaccine
Unexpected Protein Structure May Lead to New Cancer Treatments
World-First Preventative Lung Cancer Vaccine Enters Clinical Trial
Cyclana Bio Secures £5M to Transform Drug Discovery for Endometriosis
14th December, 2025
Positive Phase 1 data highlight strong safety, lung retention and momentum toward a new inhaled therapy for people with cystic fibrosis.
11th December, 2025
Financing follows major CMS coverage decision for CCM therapy and supports next-generation heart failure devices.
7th December, 2025
4th December, 2025
Largest genetic investigation of ME to date points to clear biological drivers and future clinical trial paths.
Editor's Selects.
Weighing the Cost of Semaglutide
01.
Women's Health Therapeutics Market Enters Transformative Growth Phase
02.
Feeding The Future of Medicine
03.
Biotechnology in Agriculture - Feeding the World’s Growing Population
04.
Event Spotlight.
Explore the key upcoming industry events.
Stay up-to-date. Connect with BioFocus on LinkedIn or subscribe to our mailing list.
